RUNX Proteins as Epigenetic Modulators in Cancer

被引:6
|
作者
Yi, Hongyang [1 ,2 ,3 ,4 ]
He, Yuhao [1 ,2 ]
Zhu, Qionghua [1 ,2 ]
Fang, Liang [1 ,2 ,5 ]
机构
[1] Southern Univ Sci & Technol, Sch Life Sci, Shenzhen Key Lab Gene Regulat & Syst Biol, Shenzhen 518055, Peoples R China
[2] Southern Univ Sci & Technol, Sch Life Sci, Dept Biol, Shenzhen 518055, Peoples R China
[3] Southern Univ Sci & Technol, Peoples Hosp Shenzhen 3, Natl Clin Res Ctr Infect Dis, Shenzhen 518112, Peoples R China
[4] Southern Univ Sci & Technol, Affiliated Hosp 2, Shenzhen 518112, Peoples R China
[5] Southern Univ Sci & Technol, Acad Adv Interdisciplinary Studies, Shenzhen 518005, Peoples R China
关键词
RUNX family; cancer; function; regulation; epigenetic modulator; TRANSCRIPTION FACTOR RUNX2; EPITHELIAL-MESENCHYMAL TRANSITION; CBF-BETA MUTATIONS; TEAD-YAP COMPLEX; BREAST-CANCER; TUMOR-SUPPRESSOR; PROSTATE-CANCER; GROWTH-FACTOR; STEM-CELLS; PROMOTER HYPERMETHYLATION;
D O I
10.3390/cells11223687
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
RUNX proteins are highly conserved in metazoans and perform critical functions during development. Dysregulation of RUNX proteins through various molecular mechanisms facilitates the development and progression of various cancers, where different RUNX proteins show tumor type-specific functions and regulate different aspects of tumorigenesis by cross-talking with different signaling pathways such as Wnt, TGF-beta, and Hippo. Molecularly, they could serve as transcription factors (TFs) to activate their direct target genes or interact with many other TFs to modulate chromatin architecture globally. Here, we review the current knowledge on the functions and regulations of RUNX proteins in different cancer types and highlight their potential role as epigenetic modulators in cancer.
引用
收藏
页数:14
相关论文
共 50 条
  • [1] Epigenetic gene silencing by Runx proteins
    Ichiro Taniuchi
    Dan R Littman
    Oncogene, 2004, 23 : 4341 - 4345
  • [2] Epigenetic gene silencing by Runx proteins
    Taniuchi, I
    Littman, DR
    ONCOGENE, 2004, 23 (24) : 4341 - 4345
  • [3] Epigenetic modulators of thyroid cancer
    Rodriguez-Rodero, Sandra
    Delgado-Alvarez, Elias
    Diaz-Naya, Lucia
    Martin Nieto, Alicia
    Menendez Torre, Edelmiro
    ENDOCRINOLOGIA DIABETES Y NUTRICION, 2017, 64 (01): : 44 - 56
  • [4] Epigenetic Modulators as Therapeutic Agents in Cancer
    Patnaik, Eshaan
    Madu, Chikezie
    Lu, Yi
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (19)
  • [5] Flavonoids as Epigenetic Modulators for Prostate Cancer Prevention
    Izzo, Simona
    Naponelli, Valeria
    Bettuzzi, Saverio
    NUTRIENTS, 2020, 12 (04)
  • [6] Epigenetic modulators as therapeutic targets in prostate cancer
    Inês Graça
    Eva Pereira-Silva
    Rui Henrique
    Graham Packham
    Simon J. Crabb
    Carmen Jerónimo
    Clinical Epigenetics, 2016, 8
  • [7] Epigenetic modulators as therapeutic targets in prostate cancer
    Graca, Ines
    Pereira-Silva, Eva
    Henrique, Rui
    Packham, Graham
    Crabb, Simon J.
    Jeronimo, Carmen
    CLINICAL EPIGENETICS, 2016, 8
  • [8] Epigenetic inactivation of RUNX3 in colorectal cancer
    Shin, Eung Jin
    Kim, Han Jo
    Son, Myoung Won
    Ahn, Tae Sung
    Lee, Hyun Yong
    Lim, Dae Ro
    Bae, Sang Byung
    Jeon, Seob
    Kim, Hyungjoo
    Jeong, Dongjun
    Lee, Moon Soo
    Kim, Dong-Sun
    Noh, Jeong Se
    Baek, Moo-Jun
    ANNALS OF SURGICAL TREATMENT AND RESEARCH, 2018, 94 (01) : 19 - 25
  • [9] RUNX Proteins in Development and Cancer Overview
    Speck, Nancy A.
    Ito, Yoshiaki
    RUNX PROTEINS IN DEVELOPMENT AND CANCER, 2017, 962 : XV - XX
  • [10] HDAC-targeting epigenetic modulators for cancer immunotherapy
    Cheng, Binbin
    Pan, Wei
    Xiao, Yao
    Ding, Zongbao
    Zhou, Yingxing
    Fei, Xiaoting
    Liu, Jin
    Su, Zhenhong
    Peng, Xiaopeng
    Chen, Jianjun
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2024, 265